{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:28:35Z","timestamp":1786728515202,"version":"build-2736575974"},"reference-count":165,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Schizophrenia is a chronic, severe mental disorder associated with significant disability, caregiver burden, and public health impact, particularly in low- and middle-income countries such as India. While multiple international clinical practice guidelines (CPGs) exist, contextual differences in illness presentation, sociocultural factors, health-care infrastructure, and resource availability necessitate region-specific guidance. This CPG provides a comprehensive, stage-based overview of the assessment and management of schizophrenia, with an emphasis on applicability to the Indian context. The document synthesizes available evidence, existing guideline recommendations, and expert clinical consensus to outline pragmatic approaches across the illness trajectory, including the prodromal phase, first-episode psychosis, multiepisode relapsing\u2013remitting course, and treatment-resistant schizophrenia. Detailed recommendations are provided for clinical assessment, use of standardized rating scales, physical and laboratory investigations, and identification of comorbid medical and psychiatric conditions at each stage. Pharmacological strategies emphasize rational antipsychotic use, including early intervention principles, maintenance treatment, long-acting injectable antipsychotics, therapeutic drug monitoring\u2014particularly for clozapine\u2014and evidence-based augmentation approaches in treatment resistance. The guideline also addresses emergency management, antipsychotic switching strategies, and the judicious use of combination and adjuvant psychotropic therapies. Equally, it highlights the critical role of psychological and psychosocial interventions, family involvement, community-based care, and rehabilitation services in achieving functional recovery. Special attention is given to implementation challenges and adaptations relevant to Indian clinical settings, including cost, accessibility, family structures, and public mental health systems. Overall, this guideline aims to support clinicians in delivering individualized, evidence-informed, and contextually appropriate care for persons with schizophrenia, thereby improving long-term outcomes and quality of life.<\/jats:p>","DOI":"10.4103\/indianjpsychiatry_1341_25","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:00:30Z","timestamp":1769508030000},"page":"94-121","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical practice guidelines for management of schizophrenia in India: A comprehensive overview"],"prefix":"10.4103","volume":"68","author":[{"given":"Swapnajeet","family":"Sahoo","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanteemar S.","family":"Sreeraj","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesan","family":"Gopalakrishnan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, MVJ Medical College and Research Hospital, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahul","family":"Ameen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, St. Thomas Hospital, Changanacherry, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmin M.","family":"Cholera","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Dr. D. Y. Patil Hospital and Medical College, Navi Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesan","family":"Venkatasubramanian","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India"},{"name":"Senior Consultant Psychiatrist, Fortis Hospital, Mohali, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"R1-20260420","first-page":"211","article-title":"The staging model in schizophrenia, and its clinical implications","volume":"22","author":"Agius","year":"2010","journal-title":"Psychiatr Danub"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ajp.2009.04.003","article-title":"Is the course and outcome of schizophrenia better in the \u2018developing\u2019 world?","volume":"2","author":"Kulhara","year":"2009","journal-title":"Asian J Psychiatry"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/schbul\/17.1.51","article-title":"The diagnosis of schizophrenia: A review of onset and duration issues","volume":"17","author":"Keith","year":"1991","journal-title":"Schizophr Bull"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1751-7893.2009.00148.x","article-title":"Review of the operational definition for first-episode psychosiseip","volume":"3","author":"Breitborde","year":"2009","journal-title":"Early Interv Psychiatry"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2147\/PRBM.S423865","article-title":"Identification of psychosis risk and diagnosis of first-episode psychosis: Advice for clinicians","volume":"17","author":"Lundin","year":"2024","journal-title":"Psychol Res Behav Manag"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-resistant schizophrenia: Treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am J Psychiatry"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/schbul\/sbs104","article-title":"Status of psychotic disorders in ICD-11","volume":"38","author":"Gaebel","year":"2012","journal-title":"Schizophr Bull"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1022034115078","article-title":"Symptom assessment in schizophrenic prodromal states","volume":"70","author":"Miller","year":"1999","journal-title":"Psychiatr Q"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/oxfordjournals.schbul.a007040","article-title":"Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: Predictive validity, interrater reliability, and training to reliability","volume":"29","author":"Miller","year":"2003","journal-title":"Schizophr Bull"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000106311","article-title":"Reliability of measuring anomalous experience: The Bonn Scale for the Assessment of Basic Symptoms","volume":"40","author":"Vollmer-Larsen","year":"2007","journal-title":"Psychopathology"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1192\/S0007125000297602","article-title":"Prediction of psychosis. A step towards indicated prevention of schizophrenia","volume":"172","author":"Yung","year":"1998","journal-title":"Br J Psychiatry Suppl"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-2008-1038155","article-title":"[The Basel Screening Instrument for Psychosis (BSIP): Development, structure, reliability and validity]","volume":"76","author":"Riecher-R\u00f6ssler","year":"2008","journal-title":"Fortschr Neurol Psychiatr"},{"key":"R14-20260420","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4103\/0019-5545.64583","article-title":"Effects of duration of untreated psychosis on long-term outcome of people hospitalized with first episode schizophrenia","volume":"52","author":"Shrivastava","year":"2010","journal-title":"Indian J Psychiatry"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/schbul\/sbac103","article-title":"Clinical recovery among individuals with a first-episode schizophrenia an updated systematic review and meta-analysis","volume":"49","author":"Hansen","year":"2023","journal-title":"Schizophr Bull"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"897","DOI":"10.5498\/wjp.v12.i7.897","article-title":"Social media and schizophrenia: An update on clinical applications","volume":"12","author":"Fonseka","year":"2022","journal-title":"World J Psychiatry"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.biopsych.2025.02.889","article-title":"The Neuropsychiatric checklist for Autoimmune psychosis: A narrative review","volume":"98","author":"Tebartz van Elst","year":"2025","journal-title":"Biol Psychiatry"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1038\/s41380-021-01025-0","article-title":"Vitamin D and schizophrenia: 20 years on","volume":"26","author":"Cui","year":"2021","journal-title":"Mol Psychiatry"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4103\/ijmr.IJMR_3724_20","article-title":"Serum vitamin D level in patients with schizophrenia: A community-based study","volume":"156","author":"Rajith","year":"2022","journal-title":"Indian J Med Res"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ebiom.2017.11.027","article-title":"Vitamin D Supplementation in chronic schizophrenia patients treated with clozapine: A randomized, double-blind, placebo-controlled clinical trial","volume":"26","author":"Krivoy","year":"2017","journal-title":"EBioMedicine"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/17425255.2021.1974400","article-title":"Therapeutic drug monitoring of clozapine in adults with schizophrenia: A review of challenges and strategies","volume":"17","author":"Molden","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R22-20260420","first-page":"117","article-title":"Plasma clozapine concentrations as a predictor of clinical response: A follow-up study","volume":"55","author":"Miller","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: Update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1192\/bja.2022.71","article-title":"Therapeutic monitoring of plasma clozapine and N-desmethylclozapine (norclozapine): Practical considerations","volume":"29","author":"Flanagan","year":"2023","journal-title":"BJPsych Adv"},{"key":"R25-20260420","first-page":"CD004718","article-title":"Early intervention for psychosis","volume":"6","author":"Marshall","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R26-20260420","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/a-1854-0185","article-title":"Pharmacological treatment of early-onset schizophrenia: A critical review, evidence-based clinical guidance and unmet needs","volume":"55","author":"Lopez-Morinigo","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"R27-20260420","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100578","article-title":"Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care","author":"Fusar-Poli","year":"2020","journal-title":"EClinicalMedicine"},{"key":"R28-20260420","doi-asserted-by":"crossref","first-page":"102005","DOI":"10.1016\/j.cpr.2021.102005","article-title":"Preventive interventions for individuals at ultra high risk for psychosis: An updated and extended meta-analysis","volume":"86","author":"Mei","year":"2021","journal-title":"Clin Psychol Rev"},{"key":"R29-20260420","first-page":"CD012236","article-title":"Interventions for prodromal stage of psychosis","volume":"2019","author":"Bosnjak Kuharic","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R30-20260420","article-title":"Pharmacologic treatment of first-episode schizophrenia: A review of the literature","volume":"14","author":"Thomas","year":"2012","journal-title":"Prim Care Companion CNS Disord"},{"key":"R31-20260420","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2165\/11314280-000000000-00000","article-title":"Antipsychotic drugs for first-episode schizophrenia: A comparative review","volume":"23","author":"Salimi","year":"2009","journal-title":"CNS Drugs"},{"key":"R32-20260420","doi-asserted-by":"crossref","first-page":"e013881","DOI":"10.1136\/bmjopen-2016-013881","article-title":"Pharmacological guidelines for schizophrenia: A systematic review and comparison of recommendations for the first episode","volume":"7","author":"Keating","year":"2017","journal-title":"BMJ Open"},{"key":"R33-20260420","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S2215-0366(25)00031-8","article-title":"INTEGRATE: International guidelines for the algorithmic treatment of schizophrenia","volume":"12","author":"McCutcheon","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"R34-20260420","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1176\/appi.prcp.20200004","article-title":"Updating the comparative evidence on second-generation antipsychotic use with schizophrenia","volume":"2","author":"McDonagh","year":"2020","journal-title":"Psychiatr Res Clin Pract"},{"key":"R35-20260420","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1007\/s40120-025-00838-3","article-title":"The use of long-acting injectables for people with schizophrenia: Consensus panel recommendations for overcoming barriers and implementing treatment","volume":"14","author":"Kane","year":"2025","journal-title":"Neurol Ther"},{"key":"R36-20260420","doi-asserted-by":"crossref","first-page":"20451253251360400","DOI":"10.1177\/20451253251360400","article-title":"Effect of long-acting injectable antipsychotics on treatment adherence and healthcare utilization in Chinese patients with schizophrenia: A mirror-image study","volume":"15","author":"Zhang","year":"2025","journal-title":"Ther Adv Psychopharmacol"},{"key":"R37-20260420","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41537-025-00695-x","article-title":"Helping people to discontinue antipsychotics: If, when and how","volume":"11","author":"Moncrieff","year":"2025","journal-title":"Schizophrenia"},{"key":"R38-20260420","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41537-025-00697-9","article-title":"Antipsychotic treatment in schizophrenia: Balancing relapse prevention and functional recovery","volume":"11","author":"Bogers","year":"2025","journal-title":"Schizophrenia"},{"key":"R39-20260420","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jamapsychiatry.2020.2166","article-title":"Tapering antipsychotic treatment","volume":"78","author":"Horowitz","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"R40-20260420","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41537-025-00700-3","article-title":"Benefits and risks of antipsychotic discontinuation in people with first and multi-episode psychotic disorders or with schizophrenia: Why, when, how and in whom?","volume":"11","author":"Correll","year":"2025","journal-title":"Schizophrenia"},{"key":"R41-20260420","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S2215-0366(22)00230-9","article-title":"Antipsychotic maintenance treatment versus dose reduction: How the story continues","volume":"9","author":"Sommer","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"R42-20260420","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S2215-0366(22)00158-4","article-title":"Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: A systematic review and network meta-analysis","volume":"9","author":"Ostuzzi","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"R43-20260420","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1192\/bjp.2021.61","article-title":"Rates of treatment-resistant schizophrenia from first-episode cohorts: Systematic review and meta-analysis","volume":"220","author":"Siskind","year":"2022","journal-title":"Br J Psychiatry"},{"key":"R44-20260420","doi-asserted-by":"crossref","first-page":"103291","DOI":"10.1016\/j.eclinm.2025.103291","article-title":"Efficacy and tolerability of pharmacological interventions for schizophrenia non-responsive to prior treatment: A systematic review and network meta-analysis","volume":"84","author":"Samara","year":"2025","journal-title":"EClinicalMedicine"},{"key":"R45-20260420","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1017\/neu.2022.30","article-title":"Augmentation strategies for clozapine resistance: A systematic review and meta-analysis","volume":"35","author":"Grover","year":"2023","journal-title":"Acta Neuropsychiatr"},{"key":"R46-20260420","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1017\/neu.2018.32","article-title":"ECT in schizophrenia: A review of the evidence","volume":"31","author":"Grover","year":"2019","journal-title":"Acta Neuropsychiatr"},{"key":"R47-20260420","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00406-018-0869-3","article-title":"Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: A systematic review and meta-analysis","volume":"268","author":"Krause","year":"2018","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R48-20260420","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: A systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"key":"R49-20260420","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41537-021-00171-2","article-title":"Antipsychotics for negative and positive symptoms of schizophrenia: Dose-response meta-analysis of randomized controlled acute phase trials","volume":"7","author":"Sabe","year":"2021","journal-title":"NPJ Schizophr"},{"key":"R50-20260420","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1192\/j.eurpsy.2021.13","article-title":"EPA guidance on treatment of negative symptoms in schizophrenia","volume":"64","author":"Galderisi","year":"2021","journal-title":"Eur Psychiatry"},{"key":"R51-20260420","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1192\/bjp.2023.57","article-title":"Treating negative symptoms of schizophrenia: Current approaches and future perspectives","volume":"223","author":"Howes","year":"2023","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"R52-20260420","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/s41386-025-02175-3","article-title":"Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial","volume":"50","author":"Chesney","year":"2025","journal-title":"Neuropsychopharmacology"},{"key":"R53-20260420","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.schres.2020.10.006","article-title":"Efficacy of transcranial direct current stimulation in ameliorating negative symptoms and cognitive impairments in schizophrenia: A systematic review and meta-analysis","volume":"224","author":"Yu","year":"2020","journal-title":"Schizophr Res"},{"key":"R54-20260420","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.psychres.2013.12.019","article-title":"Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: A meta-analysis","volume":"215","author":"Shi","year":"2014","journal-title":"Psychiatry Res"},{"key":"R55-20260420","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/YCT.0000000000000756","article-title":"Adjuvant high-definition transcranial direct current stimulation for negative symptoms in schizophrenia: A pilot study","volume":"37","author":"Dharani","year":"2021","journal-title":"J ECT"},{"key":"R56-20260420","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.schres.2024.05.007","article-title":"Clinical effects of a yoga-based intervention for patients with schizophrenia-A six-month randomized controlled trial","volume":"269","author":"Varambally","year":"2024","journal-title":"Schizophr Res"},{"key":"R57-20260420","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.schres.2021.03.021","article-title":"Add on yoga treatment for negative symptoms of schizophrenia: A multi-centric, randomized controlled trial","volume":"231","author":"Rao","year":"2021","journal-title":"Schizophr Res"},{"key":"R58-20260420","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/YCO.0000000000000787","article-title":"Psychopharmacology of agitation in acute psychotic and manic episodes","volume":"35","author":"Stetson","year":"2022","journal-title":"Curr Opin Psychiatry"},{"key":"R59-20260420","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/15622975.2012.696143","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance","volume":"13","author":"Hasan","year":"2012","journal-title":"World J Biol Psychiatry"},{"key":"R60-20260420","first-page":"727","article-title":"Rapid tranquillisation; review of the literature and recommendations","volume":"53","author":"Bak","year":"2011","journal-title":"Tijdschr Voor Psychiatr"},{"key":"R61-20260420","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.2174\/1570159X21666230727140843","article-title":"Cognitive effects of lurasidone and cariprazine: A mini systematic review","volume":"21","author":"Olivola","year":"2023","journal-title":"Curr Neuropharmacol"},{"key":"R62-20260420","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: Systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"R63-20260420","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamapsychiatry.2015.2955","article-title":"Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: A network meta-analysis","volume":"73","author":"Samara","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"R64-20260420","first-page":"862","article-title":"Immediate vs gradual discontinuation in antipsychotic switching: A systematic review and meta-analysis","volume":"43","author":"Takeuchi","year":"2017","journal-title":"Schizophr Bull"},{"key":"R65-20260420","first-page":"CD009005","article-title":"Antipsychotic combinations for schizophrenia","volume":"2017","author":"Ortiz-Orendain","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R66-20260420","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/wps.20387","article-title":"Antipsychotic augmentation vs. monotherapy in schizophrenia: Systematic review, meta-analysis and meta-regression analysis","volume":"16","author":"Galling","year":"2017","journal-title":"World Psychiatry"},{"key":"R67-20260420","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/0269881118822171","article-title":"Clozapine augmentation strategies - a systematic meta-review of available evidence. Treatment options for clozapine resistance","volume":"33","author":"Wagner","year":"2019","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"R68-20260420","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"R69-20260420","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/2045125318772712","article-title":"TARC: Turkish aripiprazole consensus report- Aripiprazole use and switching from other antipsychotics to aripiprazole- consensus recommendations by a Turkish multidisciplinary panel","volume":"8","author":"Veznedaroglu","year":"2018","journal-title":"Ther Adv Psychopharmacol"},{"key":"R71-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4088\/JCP.15032su1","article-title":"The use of long-acting injectable antipsychotics in schizophrenia: Evaluating the evidence","volume":"77","author":"Correll","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"R72-20260420","doi-asserted-by":"crossref","first-page":"152","DOI":"10.18773\/austprescr.2019.052","article-title":"Stopping and switching antipsychotic drugs","volume":"42","author":"Keks","year":"2019","journal-title":"Aust Prescr"},{"key":"R73-20260420","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s00213-017-4616-7","article-title":"Memantine add-on to antipsychotic treatment for residual negative and cognitive symptoms of schizophrenia: A meta-analysis","volume":"234","author":"Kishi","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"R74-20260420","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3892\/etm.2021.9707","article-title":"Current perspectives in treating negative symptoms of schizophrenia: A narrative review (review)","volume":"21","author":"C\u0103p\u0103\u021b\u00een\u0103","year":"2021","journal-title":"Exp Ther Med"},{"key":"R75-20260420","doi-asserted-by":"crossref","first-page":"103375","DOI":"10.1016\/j.ajp.2022.103375","article-title":"Pharmacological and nonpharmacological augmentation treatments for clozapine-resistant schizophrenia: A systematic review and network meta-analysis with normalized entropy assessment","volume":"79","author":"Yeh","year":"2023","journal-title":"Asian J Psychiatry"},{"key":"R76-20260420","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jamapsychiatry.2018.4489","article-title":"Comparative effectiveness of adjunctive psychotropic medications in patients with schizophrenia","volume":"76","author":"Stroup","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"R77-20260420","first-page":"CD002305","article-title":"Antidepressants for people with both schizophrenia and depression","volume":"2002","author":"Whitehead","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"R78-20260420","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/appi.ajp.2016.15081035","article-title":"Efficacy and safety of antidepressants added to antipsychotics for schizophrenia: A systematic review and meta-analysis","volume":"173","author":"Helfer","year":"2016","journal-title":"Am J Psychiatry"},{"key":"R79-20260420","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1176\/appi.ps.51.5.634","article-title":"Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998","volume":"51","author":"Citrome","year":"2000","journal-title":"Psychiatr Serv"},{"key":"R80-20260420","first-page":"CD003834","article-title":"Lithium for schizophrenia","volume":"2015","author":"Leucht","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R81-20260420","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/brainsci13020173","article-title":"Benzodiazepines and mood stabilizers in schizophrenia patients treated with oral versus long-acting injectable antipsychotics\u2014an observational study","volume":"13","author":"Miron","year":"2023","journal-title":"Brain Sci"},{"key":"R82-20260420","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/01.wnf.0000173714.61744.e6","article-title":"Efficacy and tolerability of low-dose donepezil in schizophrenia","volume":"28","author":"Erickson","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"R83-20260420","doi-asserted-by":"crossref","first-page":"7021071","DOI":"10.1155\/2017\/7021071","article-title":"Efficacy of memantine in schizophrenic patients: A systematic review","volume":"2017","author":"Di Iorio","year":"2017","journal-title":"J Amino Acids"},{"key":"R84-20260420","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/15622975.2021.2013041","article-title":"Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce","volume":"23","author":"Sarris","year":"2022","journal-title":"World J Biol Psychiatry"},{"key":"R85-20260420","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/schbul\/sbm090","article-title":"A review of the effects of modafinil on cognition in schizophrenia","volume":"33","author":"Morein-Zamir","year":"2007","journal-title":"Schizophr Bull"},{"key":"R86-20260420","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.3390\/ijms25094824","article-title":"Nutraceuticals in psychiatric disorders: A systematic review","volume":"25","author":"Bozzatello","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R87-20260420","article-title":"Nutraceuticals and phytoceuticals in the treatment of schizophrenia: A systematic review and network meta-analysis","author":"Fornaro","year":"2024","journal-title":"Res Sq"},{"key":"R88-20260420","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12272-013-0105-7","article-title":"Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia","volume":"36","author":"Park","year":"2013","journal-title":"Arch Pharm Res"},{"key":"R89-20260420","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ajp.2019.07.052","article-title":"Attitude and perceptions of patients towards long acting depot injections (LAIs)","volume":"44","author":"Grover","year":"2019","journal-title":"Asian J Psychiatry"},{"key":"R90-20260420","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2147\/NDT.S167394","article-title":"Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics - expert consensus survey part 1","volume":"14","author":"Sajatovic","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R91-20260420","first-page":"S348","article-title":"Efficacy of LAI in first episode psychosis: An observational study--clinical reports","volume":"27","author":"Cervone","year":"2015","journal-title":"Psychiatr Danub"},{"key":"R92-20260420","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_389_22","article-title":"Oral versus long-acting injectable antipsychotic in first episode schizophrenia: A 12 weeks interventional study","volume":"65","author":"Kaur","year":"2023","journal-title":"Indian J Psychiatry"},{"key":"R93-20260420","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.schres.2025.03.002","article-title":"Impact of long-acting injectable antipsychotics in early psychosis: An umbrella review","volume":"277","author":"Etienne","year":"2025","journal-title":"Schizophr Res"},{"key":"R94-20260420","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/YIC.0000000000000336","article-title":"The effects of adding long-acting injectable antipsychotic drugs to clozapine on relapse and hospitalization in patients with treatment-resistant schizophrenia: A mirror-image retrospective study","volume":"36","author":"Caliskan","year":"2021","journal-title":"Int Clin Psychopharmacol"},{"key":"R95-20260420","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5498\/wjp.v11.i8.429","article-title":"Clozapine resistant schizophrenia: Newer avenues of management","volume":"11","author":"Chakrabarti","year":"2021","journal-title":"World J Psychiatry"},{"key":"R96-20260420","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/acps.13621","article-title":"Clozapine augmentation with long-acting antipsychotic injections: A case series and systematic review","volume":"148","author":"Oloyede","year":"2023","journal-title":"Acta Psychiatr Scand"},{"key":"R97-20260420","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4103\/IJPSYM.IJPSYM_269_19","article-title":"Olanzapine pamoate use for schizophrenia: Retrospective records based study from a Tertiary Care Hospital","volume":"42","author":"Grover","year":"2020","journal-title":"Indian J Psychol Med"},{"key":"R98-20260420","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/pharmaceutics16010028","article-title":"Long-acting injectable antipsychotics\u2014a review on formulation and in vitro dissolution","volume":"16","author":"Markowicz-Piasecka","year":"2023","journal-title":"Pharmaceutics"},{"key":"R99-20260420","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(13)62629-X","article-title":"Effectiveness of a community-based intervention for people with schizophrenia and their caregivers in India (COPSI): A randomised controlled trial","volume":"383","author":"Chatterjee","year":"2014","journal-title":"Lancet"},{"key":"R100-20260420","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1192\/bji.2019.18","article-title":"Influence of the new mental health legislation in India","volume":"17","author":"Chadda","year":"2020","journal-title":"BJPsych Int"},{"key":"R101-20260420","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.schres.2023.01.008","article-title":"Psychoeducation for individuals at clinical high risk for psychosis: A scoping review","volume":"252","author":"Herrera","year":"2023","journal-title":"Schizophr Res"},{"key":"R102-20260420","first-page":"CD002831","article-title":"Psychoeducation for schizophrenia","volume":"2011","author":"Xia","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R103-20260420","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5498\/wjp.v1.i1.4","article-title":"Family interventions in schizophrenia: Issues of relevance for Asian countries","volume":"1","author":"Chakrabarti","year":"2011","journal-title":"World J Psychiatry"},{"key":"R104-20260420","first-page":"CD009006","article-title":"Social skills programmes for schizophrenia","volume":"2015","author":"Almerie","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"R105-20260420","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1093\/schbul\/sbl023","article-title":"Recent advances in social skills training for schizophrenia","volume":"32","author":"Kopelowicz","year":"2006","journal-title":"Schizophr Bull"},{"issue":"Suppl 2","key":"R106-20260420","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.4103\/psychiatry.IndianJPsychiatry_774_19","article-title":"Clinical practice guidelines for cognitive behavioral therapy for psychotic disorders","volume":"62","author":"Avasthi","year":"2020","journal-title":"Indian J Psychiatry"},{"key":"R107-20260420","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/schbul\/sbab022","article-title":"A meta-analysis of cognitive remediation for schizophrenia: Efficacy and the role of participant and treatment factors","volume":"47","author":"Lejeune","year":"2021","journal-title":"Schizophr Bull"},{"key":"R108-20260420","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11920-022-01329-0","article-title":"Models of care of schizophrenia in the community-an international perspective","volume":"24","author":"Gowda","year":"2022","journal-title":"Curr Psychiatry Rep"},{"key":"R109-20260420","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/0973-6131.98212","article-title":"Yoga therapy for Schizophrenia","volume":"5","author":"Bangalore","year":"2012","journal-title":"Int J Yoga"},{"key":"R110-20260420","first-page":"CD015260","article-title":"Psychosocial telemedicine interventions for schizophrenia","volume":"2024","author":"Kimhy","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"R111-20260420","doi-asserted-by":"crossref","first-page":"903","DOI":"10.4103\/indianjpsychiatry_657_25","article-title":"Making early intervention for psychosis feasible in India: Lessons from two decades of SCARF\u2019s first episode psychosis program","volume":"67","author":"Thara","year":"2025","journal-title":"Indian J Psychiatry"},{"key":"R112-20260420","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.schres.2020.03.041","article-title":"A systematic review and meta-analysis of cognitive behavioural informed psychological interventions for psychiatric inpatients with psychosis","volume":"222","author":"Wood","year":"2020","journal-title":"Schizophr Res"},{"key":"R113-20260420","doi-asserted-by":"crossref","first-page":"sgaa023","DOI":"10.1093\/schizbullopen\/sgaa023","article-title":"Meta-analysis and meta-regression of cognitive behavioral therapy for psychosis (CBTp) across time: The effectiveness of CBTp has improved for delusions","volume":"1","author":"Sitko","year":"2020","journal-title":"Schizophr Bull Open"},{"key":"R114-20260420","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1017\/S0033291724000564","article-title":"Do metacognitive therapies for schizophrenia-spectrum disorders work? A meta-analytic investigation","volume":"54","author":"Melville","year":"2024","journal-title":"Psychol Med"},{"key":"R115-20260420","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/schbul\/sbz134","article-title":"Compensatory interventions for cognitive impairments in psychosis: A systematic review and meta-analysis","volume":"46","author":"Allott","year":"2020","journal-title":"Schizophr Bull"},{"key":"R116-20260420","doi-asserted-by":"crossref","first-page":"100246","DOI":"10.1016\/j.ejpsy.2023.100246","article-title":"The efficacy of social skills training (SST) and social cognition and interaction training (SCIT) for negative symptoms: A meta-analysis","volume":"38","author":"Wang","year":"2024","journal-title":"Eur J Psychiatry"},{"key":"R117-20260420","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/schbul\/sbx146","article-title":"A meta-analysis of social skills training and related interventions for psychosis","volume":"44","author":"Turner","year":"2018","journal-title":"Schizophr Bull"},{"key":"R118-20260420","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1017\/S2045796022000300","article-title":"Who benefits from individual placement and support? A meta-analysis","volume":"31","author":"de Winter","year":"2022","journal-title":"Epidemiol Psychiatr Sci"},{"key":"R119-20260420","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1192\/bjp.2019.54","article-title":"Self-management interventions for people with severe mental illness: Systematic review and meta-analysis","volume":"214","author":"Lean","year":"2019","journal-title":"Br J Psychiatry"},{"key":"R120-20260420","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.3390\/ijerph17134690","article-title":"Mindfulness-based interventions for people with schizophrenia: A systematic review and meta-analysis","volume":"17","author":"Hodann-Caudevilla","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"R121-20260420","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.genhosppsych.2019.11.002","article-title":"Physical exercise for negative symptoms of schizophrenia: Systematic review of randomized controlled trials and meta-analysis","volume":"62","author":"Sabe","year":"2020","journal-title":"Gen Hosp Psychiatry"},{"key":"R122-20260420","doi-asserted-by":"crossref","first-page":"103102","DOI":"10.1016\/j.ajp.2022.103102","article-title":"Modified assertive community treatment program for patients with schizophrenia: Effectiveness and perspectives of service consumers from a South Indian setting","volume":"73","author":"Arahanthabailu","year":"2022","journal-title":"Asian J Psychiatry"},{"key":"R123-20260420","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/YCO.0000000000000925","article-title":"Evidence-based psychosocial interventions in schizophrenia: A critical review","volume":"37","author":"Barlati","year":"2024","journal-title":"Curr Opin Psychiatry"},{"key":"R124-20260420","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.schres.2025.08.018","article-title":"Does adjunctive electro-convulsive therapy improve the speed of treatment response in schizophrenia? A systematic review and week-by-week meta-analyses of controlled clinical trials","volume":"285","author":"Pantoji","year":"2025","journal-title":"Schizophr Res"},{"key":"R125-20260420","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_491_22","article-title":"Clinical practice guidelines for the use of electroconvulsive therapy","volume":"65","author":"Thirthalli","year":"2023","journal-title":"Indian J Psychiatry"},{"key":"R126-20260420","doi-asserted-by":"crossref","first-page":"115728","DOI":"10.1016\/j.psychres.2024.115728","article-title":"Efficacy of repetitive transcranial magnetic stimulation (rTMS) on negative symptoms and cognitive functioning in schizophrenia: An umbrella review of systematic reviews and meta-analyses","volume":"333","author":"Yi","year":"2024","journal-title":"Psychiatry Res"},{"key":"R127-20260420","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/schbul\/sbae158","article-title":"Safety of rTMS for schizophrenia: A systematic review and meta-analysis","volume":"51","author":"Blyth","year":"2025","journal-title":"Schizophr Bull"},{"key":"R128-20260420","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_492_22","article-title":"Clinical practice guidelines for the therapeutic use of repetitive transcranial magnetic stimulation in neuropsychiatric disorders","volume":"65","author":"Tikka","year":"2023","journal-title":"Indian J Psychiatry"},{"key":"R129-20260420","doi-asserted-by":"crossref","first-page":"118","DOI":"10.9758\/cpn.2013.11.3.118","article-title":"Transcranial direct current stimulation in schizophrenia","volume":"11","author":"Agarwal","year":"2013","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"R130-20260420","doi-asserted-by":"crossref","first-page":"874128","DOI":"10.3389\/fpsyt.2022.874128","article-title":"A literature mini-review of transcranial direct current stimulation in schizophrenia","volume":"13","author":"Stuchl\u00edkov\u00e1","year":"2022","journal-title":"Front Psychiatry"},{"key":"R131-20260420","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamapsychiatry.2019.3199","article-title":"Efficacy and safety of transcranial direct current stimulation for treating negative symptoms in schizophrenia: A randomized clinical trial","volume":"77","author":"Valiengo","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"R132-20260420","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_496_22","article-title":"Clinical practice guidelines for the use of transcranial direct current stimulation in psychiatry","volume":"65","author":"Sreeraj","year":"2023","journal-title":"Indian J Psychiatry"},{"key":"R133-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjp.2024.150","article-title":"Clozapine monitoring requirements: Is it time for an update?","volume":"226","author":"Fernandez-Egea","year":"2025","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"R134-20260420","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1192\/j.eurpsy.2024.1816","article-title":"The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force","volume":"68","author":"Verdoux","year":"2025","journal-title":"Eur Psychiatry"},{"key":"R135-20260420","doi-asserted-by":"crossref","first-page":"779684","DOI":"10.3389\/fpsyt.2021.779684","article-title":"The importance of suicide risk formulation in schizophrenia","volume":"12","author":"Berardelli","year":"2021","journal-title":"Front Psychiatry"},{"key":"R136-20260420","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_497_22","article-title":"Clinical practice guidelines for management of suicidal behaviour","volume":"65","author":"Sarkhel","year":"2023","journal-title":"Indian J Psychiatry"},{"key":"R137-20260420","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S2215-0366(24)00441-3","article-title":"Suicide prevention in schizophrenia spectrum disorders","volume":"12","author":"Bornheimer","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"R138-20260420","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.schres.2023.11.008","article-title":"A systematic review of clozapine for aggression and violence in patients with schizophrenia or schizoaffective disorder","volume":"268","author":"Faden","year":"2024","journal-title":"Schizophr Res"},{"key":"R139-20260420","first-page":"CD005146","article-title":"Haloperidol plus promethazine for psychosis-induced aggression","volume":"2016","author":"Huf","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R140-20260420","first-page":"CD012397","article-title":"Risk assessment for aggressive behaviour in schizophrenia","volume":"2024","author":"V\u00e4lim\u00e4ki","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"R141-20260420","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11126-017-9521-z","article-title":"Clozapine in reducing aggression and violence in forensic populations","volume":"89","author":"Patchan","year":"2018","journal-title":"Psychiatr Q"},{"key":"R142-20260420","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_518_22","article-title":"Clinical practice guidelines for assessment and management of aggressive and assaultive behaviour","volume":"65","author":"Gautam","year":"2023","journal-title":"Indian J Psychiatry"},{"key":"R143-20260420","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12991-024-00529-7","article-title":"Management of schizophrenia and comorbid substance use disorders: Expert review and guidance","volume":"23","author":"Neyra","year":"2024","journal-title":"Ann Gen Psychiatry"},{"key":"R144-20260420","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/02698811231158232","article-title":"Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology","volume":"37","author":"Rogers","year":"2023","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"R145-20260420","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jamapsychiatry.2025.1818","article-title":"Risk factors for catatonia relapse in psychotic and affective disorders","volume":"82","author":"Pathak","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"R146-20260420","first-page":"29","article-title":"Diagnosis and treatment depression in schizophrenia","volume":"1","author":"Mosolov","year":"2020","journal-title":"Consort Psychiatr"},{"key":"R147-20260420","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41537-023-00364-x","article-title":"Real-world effectiveness of antidepressant use in persons with schizophrenia: Within-individual study of 61,889 subjects","volume":"9","author":"Puranen","year":"2023","journal-title":"Schizophr Heidelb Ger"},{"key":"R148-20260420","first-page":"701","article-title":"Augmentation with antidepressants in schizophrenia treatment: Benefit or risk","volume":"11","author":"Mao","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R149-20260420","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/schbul\/sbab004","article-title":"Long-term real-world effectiveness of pharmacotherapies for schizoaffective disorder","volume":"47","author":"Lintunen","year":"2021","journal-title":"Schizophr Bull"},{"key":"R150-20260420","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.rpsm.2020.05.003","article-title":"Clozapine in patients with schizoaffective disorder: A systematic review","volume":"14","author":"Rey Souto","year":"2021","journal-title":"Rev Psiquiatr Salud Ment (Engl Ed)"},{"issue":"Suppl 1","key":"R151-20260420","first-page":"S140","article-title":"Obsessive-compulsive disorder comorbid with schizophrenia and bipolar disorder","volume":"61","author":"Sharma","year":"2019","journal-title":"Indian J Psychiatry"},{"key":"R152-20260420","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/neu.2018.27","article-title":"Obsessive-compulsive symptoms in schizophrenia: A review","volume":"31","author":"Grover","year":"2019","journal-title":"Acta Neuropsychiatr"},{"key":"R153-20260420","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00737-019-0948-0","article-title":"Schizophrenia and pregnancy: A national register-based follow-up study among Finnish women born between 1965 and 1980","volume":"23","author":"Simoila","year":"2020","journal-title":"Arch Womens Ment Health"},{"issue":"Suppl 2","key":"R154-20260420","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/psychiatry.IndianJPsychiatry_556_18","article-title":"Clinical practice guidelines for the management of schizophrenia in children and adolescents","volume":"61","author":"Grover","year":"2019","journal-title":"Indian J Psychiatry"},{"key":"R155-20260420","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/schbul\/sbt043","article-title":"Treating older adults with schizophrenia: Challenges and opportunities","volume":"39","author":"Jeste","year":"2013","journal-title":"Schizophr Bull"},{"issue":"Suppl 3","key":"R156-20260420","doi-asserted-by":"crossref","first-page":"S363","DOI":"10.4103\/0019-5545.224475","article-title":"Clinical practice guideline for management of psychoses in elderly","volume":"60","author":"Gautam","year":"2018","journal-title":"Indian J Psychiatry"},{"key":"R157-20260420","doi-asserted-by":"crossref","first-page":"108520","DOI":"10.1016\/j.yebeh.2021.108520","article-title":"Epilepsy in patients with schizophrenia: Pathophysiology and basic treatments","volume":"127","author":"Adachi","year":"2022","journal-title":"Epilepsy Behav"},{"issue":"Suppl 2","key":"R158-20260420","doi-asserted-by":"crossref","first-page":"S319","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_17_22","article-title":"Management of psychiatric disorders in patients of epilepsy","volume":"64","author":"Kedare","year":"2022","journal-title":"Indian J Psychiatry"},{"key":"R159-20260420","doi-asserted-by":"crossref","first-page":"2045125319862968","DOI":"10.1177\/2045125319862968","article-title":"Treatment of psychoses in patients with epilepsy: An update","volume":"9","author":"Agrawal","year":"2019","journal-title":"Ther Adv Psychopharmacol"},{"issue":"Suppl 2","key":"R160-20260420","doi-asserted-by":"crossref","first-page":"S379","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_18_22","article-title":"Management of psychiatric disorders in patients with hepatic and gastrointestinal diseases","volume":"64","author":"Menon","year":"2022","journal-title":"Indian J Psychiatry"},{"key":"R161-20260420","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaclp.2022.09.006","article-title":"Antipsychotic safety in liver disease: A narrative review and practical guide for the clinician","volume":"64","author":"Gunther","year":"2023","journal-title":"J Acad Consult-Liaison Psychiatry"},{"issue":"Suppl 2","key":"R162-20260420","doi-asserted-by":"crossref","first-page":"S394","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_1016_21","article-title":"Management of psychiatric disorders in patients with chronic kidney diseases","volume":"64","author":"Dalal","year":"2022","journal-title":"Indian J Psychiatry"},{"key":"R163-20260420","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S2213-8587(23)00119-5","article-title":"Metabolic non-communicable disease health report of India: The ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17)","volume":"11","author":"Anjana","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R164-20260420","first-page":"163","article-title":"Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management","volume":"57","author":"Misra","year":"2009","journal-title":"J Assoc Physicians India"},{"key":"R165-20260420","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/jamapsychiatry.2025.2332","article-title":"Semaglutide treatment of antipsychotic-treated patients with schizophrenia, prediabetes, and obesity: The HISTORI randomized clinical trial","volume":"82","author":"Ganeshalingam","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"R167-20260420","doi-asserted-by":"crossref","first-page":"829","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_667_24","article-title":"Amend the Mental Health Care Act 2017: A Survey of Indian Psychiatrists (Paper 1)","volume":"66","author":"Malhotra","year":"2024","journal-title":"Indian J Psychiatry"},{"key":"R168-20260420","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_812_24","article-title":"Amend the Mental Health Care Act 2017: A survey of Indian psychiatrists (Part 2)","volume":"66","author":"Malhotra","year":"2024","journal-title":"Indian J Psychiatry"}],"container-title":["Indian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/indianjpsychiatry_1341_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:28:03Z","timestamp":1786724883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/indianjpsychiatry_1341_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":165,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/indianjpsychiatry_1341_25","relation":{},"ISSN":["0019-5545","1998-3794"],"issn-type":[{"value":"0019-5545","type":"print"},{"value":"1998-3794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-12-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}